Table 2.
Biomarkers identified as potentially regulated by catalpol.
| Proposed identity | Compound | VIP | Theoretical (m/z) | Experimental (m/z) | Error (ppm) | Formula | RT | Ion mode | MS/MS fragment ions | Change trend (Mod/B) | Change trend (HCat/Mod) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| L-carnitine | Amino acid analogs | 7.08124 | 162.11246 | 162.11198 | −3.207 | C7H15NO3 | 1.503 | [M + H]+ | 103 (42.25), 60 (31), 102 (14.90), 58 (19.77) | ↑** | ↓## |
| N-Propyl-N-nitrosourea | Nitrosoureas | 4.42921 | 132.07675 | 132.07642 | −2.522 | C4H9N3O2 | 1.52 | [M + H]+ | 87 (5.63), 114 (2.88), 115 (1.39) | ↑* | ↓# |
| Benserazide | Aromatics | 4.89159 | 258.10844 | 258.10901 | 2.181 | C10H15N3O5 | 1.522 | [M + H]+ | 139 (100), 107 (41.31), 258 (6.48) | ↑* | ↓# |
| Non-anoylcarnitine | Amino acid analogs | 3.03583 | 302.23258 | 302.23423 | −2.129 | C16H31NO4 | 1.614 | [M + H]+ | 85 (100), 302 (56), 243 (8) | ↑* | ↓# |
| 3-Hydroxy-1-methylpyrrolidine-2,5-dione | Pyrrolidinones | 2.14781 | 128.03531 | 128.03398 | −1.871 | C5H7NO3 | 1.641 | [M − H]− | 58 (100), 42 (79.53), 83 (2.15) | ↓** | ↑ |
| Lactic Acid | Carboxylic acids | 5.756 | 88.01524 | 88.01291 | −4.162 | C3H6O3 | 1.705 | [M − H]− | 89 (100), 71 (46.84), 43 (23.52) | ↑** | ↓## |
| 2-Acetylpyrazine | Pyrazines | 1.32922 | 123.05528 | 123.05516 | −1.052 | C6H6N2O | 2.62 | [M + H]+ | 96 (4.04), 78 (1.85), 53 (0.73) | ↑** | ↓# |
| Isonicotinamide | Pyridines | 2.03894 | 123.05528 | 123.0551 | −1.539 | C6H6N2O | 2.975 | [M + H]+ | 80 (16.26), 78 (1.85), 106 (0.95), 53 (0.73) | ↑*** | ↓# |
| Tetraethylene glycol | Alcohols | 2.4462 | 195.12270 | 195.12238 | −1.641 | C8H18O5 | 3.578 | [M + H]+ | 89 (100), 133 (17.67), 107 (2.52) | ↑*** | ↓## |
| Pivaloylcarnitine | Amino acid analogs | 1.47363 | 246.16998 | 246.16846 | 4.715 | C12H23NO4 | 5.021 | [M + H]+ | 85 (100), 187 (8.26) | ↑* | ↓# |
| Pteridine | Aromatics | 2.83258 | 131.03631 | 131.03496 | −2.005 | C6H4N4 | 5.791 | [M − H]− | 131 (100), 77 (10.18), 104 (4.51) | ↓*** | ↑### |
| Metenamine | Triazinane | 2.76181 | 141.11347 | 141.11304 | −3.068 | C6H12N4 | 14.463 | [M + H]+ | 141 (100), 85 (26.58), 98 (14.28), 71 (6.99), | ↓** | ↑ |
| Docosahexaenoic Acid | Polyunsaturated fatty acids | 7.10215 | 327.23295 | 327.23343 | 4.808 | C22H32O2 | 17.838 | [M − H]− | 59 (100), 121 (5.99), 139 (4.60) | ↑** | ↓ |
| 9-Octadecenamide | Amides | 2.8295 | 282.27914 | 282.27744 | −4.27 | C18H35NO | 18.148 | [M + H]+ | 69 (100), 55 (63.31), 57 (54.70), 81 (32.10), 71 (30.60), 67 (19.48) | ↑*** | ↓# |
| Bovinic acid | Linoleic acids | 1.3011 | 279.23295 | 279.23236 | 1.802 | C18H32O2 | 18.805 | [M − H]− | 279 (100), 280 (22.90) | ↑** | ↓## |
| Stearic acid | Fatty acids | 3.05534 | 283.26425 | 283.26379 | 2.235 | C18H36O2 | 18.805 | [M − H]− | 283 (100), 284 (20.98) | ↑*** | ↓### |
| trideca-6,8,10-trienoic acid | Fatty acids | 1.79847 | 209.15360 | 209.15327 | −2.899 | C13H20O2 | 19.011 | [M + H]+ | 89 (100), 103 (17.11), 53 (2.43) | ↑** | ↓### |
| 13-Docosenamide | Amides | 7.23946 | 338.34174 | 338.34085 | −2.635 | C22H43NO | 19.562 | [M + H]+ | 69 (100), 57 (77.64), 83 (61.17), 55 (68.67), 71 (37.89) | ↑* | ↓### |
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, B vs. Mod; #p < 0.05, ##p < 0.01, and ###p < 0.001, HCat vs. Mod. The structures, molecular weights, and codes of differential metabolites were assigned according to the Human Metabolome Database.